National Cancer Research Network
 
Home | News |Library | Trials Units |About Us | Research Networks |NIHR Portal| Contact

 

National Institute for Health Research

 
Home arrow Clinical Studies Groups arrow Complementary Therapies  
 

 

Complementary Therapies PDF Print E-mail
Complementary Therapies Development Group


Chair

Mr Andrew Ritchie

Further details of the Groups' activities are available from Dr Eileen Loucaides
Tel: 0207 061 8582
Email:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

List of Members

  • Dr Richard Ashford
  • Dr Jane Cope (Observer)
  • Dr Deborah Fenlon
  • Ms Julie Flynn
  • Dr Karen Groot (Observer)
  • Ms Andrea Harris
  • Ms Caroline Hoffman
  • Professor Richard Kaplan (Observer)
  • Dr Michelle Kohn
  • Dr Janine Leach
  • Professor George Lewith
  • Ms Sharon Love
  • Dr Alasdair Macsween
  • Professor Alexander Molassiotis
  • Professor Kenneth Muir
  • Mrs Victoria Nnatuanya
  • Dr Fiona Reddington (Observer)
  • Professor Nicola Robinson
  • Miss Carmen Sobande  
  • Dr Dawn Storey
  • Dr Jacqui Stringer
  • Dr Hannah Whiteman (Observer)
  • Dr Teresa Young
  • Mrs Lesley Turner
  • Mrs Natalie Doyle
  • Dr John Hughes
  • Professor Janet Dunn

Latest Annual Report Information

Download Complementary Therapies CSDG 2008-9 Annual Report (PDF Format)

Download Complementary Therapies CSDG 2007-8 Annual Report (DOC Format)

Download Complementary Therapies CSDG 2005-6 Annual Report (PDF Format)

In February 2010 the NCRI Complementary Therapies Clinical Studies Development Group (CT CSDG) identified the research priorities for complementary therapy research and have developed a new 5 year strategy which will address these key areas of research. To mark the launch of the strategy, the Group have developed a new leaflet which highlights the identified research priorities and the work of the Group. A letter explaining more about the strategy and the Groups new leaflet which summarises the research priorities can be found below: 

NCRI CT CSDG Strategy Letter 2010
NCRI CT CSDG Flyer 2010

Approaching the Complementary Therapies Clinical Studies Group

If you would like to approach the Group for guidance on the necessity, feasibility, and methodology of a study or trial idea prior to the submission of a funding application, please complete and submit the trial proposal form below.

Please refer to the Trials proposal form guidance and Study development flowchart for more information on the process.

[Trials proposal form]  :  [FAQs: study development and registration]  :  [Study development flowchart]

The Coordinating Centre is a consortium of the University of Leeds, Leeds Teaching Hospitals NHS Trust, and the Medical Research Council Clinical Trials Unit. It is funded by the National Institute for Health Research with additional support from and collaboration with the National Cancer Research Institute and Cancer Research UK.
Last Updated ( Tuesday, 13 July 2010 )
 

 


Friday, 03 September 2010 

 

Search the UKCRN
Portfolio Database

UKCRN Portfolio Database Search

 
Home
About Us
News
Research Networks
Trials Portfolio
Clinical Studies Groups
Training & Education
Patient & Public Involvement
Industry
Trials Units
CPAS
Library
NCRN Jobs
Useful Links
Contact Us
NIHR Portal

 

 

 

 

NCRN Jobs

NCRN Jobs

 

Local Research
Networks

Local Research Networks

 

Download the latest NCRN Newsletter!
 

National Cancer Research Institute
 


NIHR Clinical Research Network Coordinating Centre

 

onCore
 

Cancer Research UK
 

Macmillan Cancer Support
 
EORTC  

NCRN Coordinating Centre
University of Leeds
MacMillan Wing
Fairbairn House
71-75 Clarendon Road
Leeds
LS2 9PH


enquiries@ncrn.org.uk

Tel: 0113 343 2254
Fax: 0113 343 2242

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
© National Cancer Research Network 2008 |Contact | About Us | Accessibility | NIHR Portal |

The Coordinating Centre is a consortium of the University of Leeds, Leeds Teaching Hospitals NHS Trust, and the Medical Research Council Clinical Trials Unit. It is funded by the National Institute for Health Research with additional support from and collaboration with the National Cancer Research Institute and Cancer Research UK.